Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,315,466
  • Shares Outstanding, K 126,041
  • Annual Sales, $ 739,020 K
  • Annual Income, $ -436,370 K
  • EBIT $ -442 M
  • EBITDA $ -404 M
  • 60-Month Beta 1.56
  • Price/Sales 16.70
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 58.97% ( -2.82%)
  • Historical Volatility 80.44%
  • IV Percentile 38%
  • IV Rank 20.52%
  • IV High 103.43% on 04/04/25
  • IV Low 47.50% on 08/13/25
  • Put/Call Vol Ratio 0.26
  • Today's Volume 413
  • Volume Avg (30-Day) 1,359
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 56,631
  • Open Int (30-Day) 54,958

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.81
  • Number of Estimates 4
  • High Estimate -0.76
  • Low Estimate -0.86
  • Prior Year -0.90
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.00 +59.98%
on 10/14/25
101.57 -3.92%
on 11/10/25
+33.36 (+51.95%)
since 10/10/25
3-Month
53.40 +82.74%
on 09/16/25
101.57 -3.92%
on 11/10/25
+42.49 (+77.11%)
since 08/12/25
52-Week
28.45 +243.01%
on 11/19/24
101.57 -3.92%
on 11/10/25
+67.85 (+228.24%)
since 11/12/24

Most Recent Stories

More News
Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access

34-member consortium creates an interoperable data standard for AI and distributed analytics Notable founding members include Guardant Health, NetApp,...

GH : 98.40 (+0.71%)
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring

New Guardant Reveal offering provides oncologists with tissue-free solution to monitor treatment response and detect early disease progression with unprecedented speed and sensitivity ...

GH : 98.40 (+0.71%)
Guardant Health to Participate in Upcoming Investor Conferences

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Jefferies...

GH : 98.40 (+0.71%)
1 Growth Stock with All-Star Potential and 2 That Underwhelm

1 Growth Stock with All-Star Potential and 2 That Underwhelm

NFLX : 1,154.72 (+1.61%)
GH : 98.40 (+0.71%)
AVO : 12.68 (+0.16%)
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 21, 2025, the Compensation Committee of Guardant’s Board of Directors approved the granting of...

GH : 98.40 (+0.71%)
New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response

Tissue-free Guardant Reveal test identifies disease progression up to 18 months earlier than standard clinical measures in patients with advanced cancer ...

GH : 98.40 (+0.71%)
Stocks making big moves yesterday: Clover Health, Rivian, Johnson Controls, Kratos, and Guardant Health

Stocks making big moves yesterday: Clover Health, Rivian, Johnson Controls, Kratos, and Guardant Health

JCI : 122.99 (+0.86%)
GH : 98.40 (+0.71%)
RIVN : 17.06 (-5.33%)
KTOS : 76.20 (-0.51%)
CLOV : 2.53 (-0.78%)
Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients

Published study adds to growing evidence that the Shield blood-based screening test boosts adherence

GH : 98.40 (+0.71%)
Why Guardant Health (GH) Shares Are Sliding Today

Why Guardant Health (GH) Shares Are Sliding Today

GH : 98.40 (+0.71%)
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock

Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of an upsized underwritten public offering of 3,333,333 shares of Guardant...

GH : 98.40 (+0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 101.66
2nd Resistance Point 100.48
1st Resistance Point 99.10
Last Price 98.40
1st Support Level 96.54
2nd Support Level 95.36
3rd Support Level 93.98

See More

52-Week High 101.57
Last Price 98.40
Fibonacci 61.8% 73.64
Fibonacci 50% 65.01
Fibonacci 38.2% 56.38
52-Week Low 28.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar